SUNNIVA ANNOUNCES RESIGNATION OF PRESIDENT & CO-FOUNDERSunniva Announces Resignation Of President And Co-Founder
Sunniva Inc. May 22, 2019, 16:15 ET
VANCOUVER, British Columbia, May 22, 2019 /CNW/ -- Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") (
CSE: SNN) (
OTCQB: SNNVF), a North American provider of cannabis products and services, announces Leith Pedersen, President, Chief Strategy Officer and Co-Founder of the Company has resigned as an officer and a director, effective immediately, for personal reasons. His responsibilities will be absorbed by the senior leadership team of the Company.
Dr. Anthony Holler, Chairman and CEO, commented, "On behalf of the entire Sunniva organization, I want to express my gratitude to Leith for his contributions to Sunniva over the past several years. Leith and I founded Sunniva together in 2014 and thanks in large part to his vision, energy and passion, Sunniva has progressed to be an emerging player in the California cannabis industry. We wish Leith all the best in his future endeavors."
For more information please visit:
www.sunniva.com To be added to the Sunniva email distribution list please register at
www.sunniva.com/email-alerts.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
About Sunniva Inc. Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world's two largest cannabis markets – California and Canada. In Canada, Sunniva's wholly owned subsidiary NHS operates medical cannabis clinics that provide educational and clinical services to patients. In California, Sunniva is focused on creating sustainable premium cannabis brands supported by our large-scale, purpose-built cGMP designed greenhouse and extraction facilities. We offer a steadfast commitment to safety and quality assurance providing cannabis products free from pesticides, which positions Sunniva in California as a leading provider of safe, high quality, reproducible products at scale. Through production from Phase One of our strategically positioned 325,000 square foot high technology greenhouse which is nearing completion and our fully operational Extraction Facility in California, we are launching Sunniva branded products in various product categories and price points including flower, pre-rolls, vape cartridges and premium concentrates. Sunniva branded products will be showcased within our flagship dispensary to be located at the greenhouse and our in-house marketing and distribution team will strive to ensure the placement of Sunniva branded products at licensed dispensaries throughout the state. Sunniva's management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.